473 related articles for article (PubMed ID: 33519805)
1. MicroRNAs Associated With a Good Prognosis of Acute Myeloid Leukemia and Their Effect on Macrophage Polarization.
Neaga A; Bagacean C; Tempescul A; Jimbu L; Mesaros O; Blag C; Tomuleasa C; Bocsan C; Gaman M; Zdrenghea M
Front Immunol; 2020; 11():582915. PubMed ID: 33519805
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs Associated with a Bad Prognosis in Acute Myeloid Leukemia and Their Impact on Macrophage Polarization.
Jimbu L; Mesaros O; Joldes C; Neaga A; Zaharie L; Zdrenghea M
Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255226
[TBL] [Abstract][Full Text] [Related]
3. OncomiR or antioncomiR: Role of miRNAs in Acute Myeloid Leukemia.
He C; Luo B; Jiang N; Liang Y; He Y; Zeng J; Liu J; Zheng X
Leuk Lymphoma; 2019 Feb; 60(2):284-294. PubMed ID: 30187809
[TBL] [Abstract][Full Text] [Related]
4. miRNAs in acute myeloid leukemia.
Liao Q; Wang B; Li X; Jiang G
Oncotarget; 2017 Jan; 8(2):3666-3682. PubMed ID: 27705921
[TBL] [Abstract][Full Text] [Related]
5. The pathological role and prognostic impact of miR-181 in acute myeloid leukemia.
Weng H; Lal K; Yang FF; Chen J
Cancer Genet; 2015 May; 208(5):225-9. PubMed ID: 25686674
[TBL] [Abstract][Full Text] [Related]
6. MiR-451a enhances the phagocytosis and affects both M1 and M2 polarization in macrophages.
Liu X; Zhang D; Wang H; Ren Q; Li B; Wang L; Zheng G
Cell Immunol; 2021 Jul; 365():104377. PubMed ID: 34004369
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs and acute myeloid leukemia: therapeutic implications and emerging concepts.
Wallace JA; O'Connell RM
Blood; 2017 Sep; 130(11):1290-1301. PubMed ID: 28751524
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.
Trino S; Lamorte D; Caivano A; Laurenzana I; Tagliaferri D; Falco G; Del Vecchio L; Musto P; De Luca L
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401684
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia.
Mi S; Lu J; Sun M; Li Z; Zhang H; Neilly MB; Wang Y; Qian Z; Jin J; Zhang Y; Bohlander SK; Le Beau MM; Larson RA; Golub TR; Rowley JD; Chen J
Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19971-6. PubMed ID: 18056805
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA: an important regulator in acute myeloid leukemia.
Wang X; Chen H; Bai J; He A
Cell Biol Int; 2017 Sep; 41(9):936-945. PubMed ID: 28370893
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic regulation of miRNA genes in acute leukemia.
Agirre X; Martínez-Climent JÁ; Odero MD; Prósper F
Leukemia; 2012 Mar; 26(3):395-403. PubMed ID: 22143672
[TBL] [Abstract][Full Text] [Related]
12. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-150 expression induces myeloid differentiation of human acute leukemia cells and normal hematopoietic progenitors.
Morris VA; Zhang A; Yang T; Stirewalt DL; Ramamurthy R; Meshinchi S; Oehler VG
PLoS One; 2013; 8(9):e75815. PubMed ID: 24086639
[TBL] [Abstract][Full Text] [Related]
14. Characterization of miRNomes in acute and chronic myeloid leukemia cell lines.
Xiong Q; Yang Y; Wang H; Li J; Wang S; Li Y; Yang Y; Cai K; Ruan X; Yan J; Hu S; Fang X
Genomics Proteomics Bioinformatics; 2014 Apr; 12(2):79-91. PubMed ID: 24755403
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of specific microRNA and their targets in acute myeloid leukemia.
Cammarata G; Augugliaro L; Salemi D; Agueli C; La Rosa M; Dagnino L; Civiletto G; Messana F; Marfia A; Bica MG; Cascio L; Floridia PM; Mineo AM; Russo M; Fabbiano F; Santoro A
Am J Hematol; 2010 May; 85(5):331-9. PubMed ID: 20425795
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-based therapies: Revolutionizing the treatment of acute myeloid leukemia.
Chandraprabha Vineetha R; Anitha Geetha Raj J; Devipriya P; Sreelatha Mahitha M; Hariharan S
Int J Lab Hematol; 2024 Feb; 46(1):33-41. PubMed ID: 38105344
[TBL] [Abstract][Full Text] [Related]
17. Tumor suppressors in acute myeloid leukemia.
Wallwitz J; Aigner P; Stoiber D
Leuk Lymphoma; 2021 Oct; 62(10):2320-2330. PubMed ID: 33929273
[TBL] [Abstract][Full Text] [Related]
18. Selection of three miRNA signatures with prognostic value in non-M3 acute myeloid leukemia.
Xue Y; Ge Y; Kang M; Wu C; Wang Y; Rong L; Fang Y
BMC Cancer; 2019 Jan; 19(1):109. PubMed ID: 30700251
[TBL] [Abstract][Full Text] [Related]
19. New insight into the role of miRNAs in leukemia.
Zhang H; Chen Y
Sci China C Life Sci; 2009 Mar; 52(3):224-31. PubMed ID: 19294347
[TBL] [Abstract][Full Text] [Related]
20. The miR-23a∼27a∼24-2 microRNA Cluster Promotes Inflammatory Polarization of Macrophages.
Boucher A; Klopfenstein N; Hallas WM; Skibbe J; Appert A; Jang SH; Pulakanti K; Rao S; Cowden Dahl KD; Dahl R
J Immunol; 2021 Feb; 206(3):540-553. PubMed ID: 33328213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
